Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 18-Apr-24 4:01 PM View:  | Arcellx, Inc. (ACLX) | 16-Apr-24 | Option Exercise | 9,402 | $7.61 | $71,549.20 | 100% 0 to 9.4K | |
| 18-Apr-24 4:01 PM View: | Arcellx, Inc. (ACLX) | 16-Apr-24 | Planned Option Sale | 9,402 | $55.55 | $522,260.00 | (100%) 9.4K to 0 | |
| 18-Mar-24 6:38 PM View: | Arcellx, Inc. (ACLX) | 15-Mar-24 | Option Exercise | 9,000 | $7.61 | $68,490.00 | 100% 0 to 9.0K | |
| 18-Mar-24 6:38 PM View: | Arcellx, Inc. (ACLX) | 15-Mar-24 | Planned Option Sale | 9,000 | $70.40 | $633,582.00 | (100%) 9.0K to 0 | |
| 05-May-23 5:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-May-23 | Grant | 3,534 | -- | -- | 27% 13.14K to 16.68K | |
| 06-May-22 6:17 PM View: | Revance Therapeutics, Inc. (RVNC) | 04-May-22 | Grant | 6,059 | -- | -- | 86% 7.08K to 13.14K | |
| 07-May-21 7:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-May-21 | Grant | 674 | -- | -- | 11% 6.41K to 7.08K | |
| 10-Mar-21 7:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 08-Mar-21 | Grant | 6,408 | -- | -- | 100% 0 to 6.41K |